All problems

For UK private dental practices

You're planning to sell, but you don't yet know what the business is worth

Dental practice sale prices are driven by EBITDA and the multiple an acquirer applies, and both are movable before you go to market. What you do in the next one to three years determines the final figure.

Two minutes. Solva follows up with specific valuation and exit-readiness options.

  • Receiving lower-than-expected offers for the practice.
  • Extended sales processes due to identified issues during due diligence.
  • Difficulty in attracting corporate buyers due to poor financial hygiene.
  • Personal expenses intertwined with business finances, obscuring true profitability.
  • Inefficient practice operations due to lack of optimisation.
  • Increased workload for practice owners trying to manage the sale process while running the business.
  • Reduced sale price for the practice, potentially by hundreds of thousands of pounds.
  • Increased costs associated with prolonged sales processes or remedial actions.
  • Negative perception of the practice in the market due to identified operational issues.
  • Difficulty in attracting future buyers if the practice gains a reputation for being problematic.

No verified UK data available for specific percentages (Christie and Co, 2024)

Source: https://www.christie.com/news-resources/publications/dental-market-review-2024/

Frequently asked questions

Why does this problem persist?

Dental practice valuations are primarily driven by EBITDA (earnings before interest, tax, depreciation and amortisation) and the multiple applied by acquirers. Corporate dental groups, which now account for over 40% of UK dental acquisitions, apply multiples of 5x to 9x EBITDA for well-run practices. Many practice owners approaching exit have not optimised their EBITDA, have personal expenses running through the business, or have operational weaknesses that will be identified in due diligence and used to reduce the offer price. Two to three years of preparation can increase the sale price by 30% to 60%.

What is the cost of leaving it unaddressed?

No verified UK data available for specific cost ranges (Christie and Co, 2024)

This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.

Related problems

Solvable.Health© 2026

This information is for educational purposes only and does not constitute professional advice.